Crescent Biopharma, Inc. (CBIO) Operating margin 2016–2025
Crescent Biopharma, Inc. (CBIO) operating margin by fiscal year — reported operating income divided by reported revenue.
-1407.5%FY2025 · since FY2016: -172505.3% → -1407.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1407.5% | — |
| FY2023 | -392752.9% | -329548.5 pp |
| FY2022 | -63204.4% | -57733.7 pp |
| FY2021 | -5470.7% | -4963.8 pp |
| FY2020 | -506.8% | — |
| FY2016 | -172505.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice